Literature DB >> 25931949

Minimally invasive parathyroidectomy without using intraoperative parathyroid hormone monitoring or gamma probe.

Aykut Soyder1, Mustafa Ünübol2, İmran Kurt Ömürlü3, Engin Güney2, Serdar Özbaş4.   

Abstract

OBJECTIVE: Minimal invasive parathyroidectomy (MIP) is a common surgical technique for the treatment of primary hyperparathyroidism (PHPT) and is usually done in conjunction with positive imaging techniques. We aimed to assess the results of this technique, performed without the use of intraoperative tests, in cases with PHPT caused by a single parathyroid adenoma.
MATERIAL AND METHODS: The data for patients who were diagnosed with PHPT were assessed retrospectively. Only those who had undergone a parathyroid adenoma localization study with ultrasonography (US) and parathyroid scintigraphy (PS) before the surgery, along with those patients for whom the MIP technique was routinely performed with frozen pathology, were included.
RESULTS: The study group was made up of 65 patients who had undergone the MIP technique. The mean age of the patients was 56±14 (20-81), with most being females [M/F: 19 (29.2%)/46 (70.8%)]. The mean calcium values before the operation were 11.24±1.26 mg/dL (8-15.5) (normal range: 8.4-10.2), and the parathyroid hormone (PTH) values were 388 pg/mL (249-707.75). These same values, measured 24 hours after the operation, were determined as 9.04±1.04 mg/dL (6.8-13.9) and 27 pg/mL (6-86), respectively. The follow-up period for the patients was an average of 26.6±9.4 (3-76) months, and only 3 (4.6%) cases of persistent hyperparathyroidism were detected within this period.
CONCLUSION: Our success rate with MIP in PHPT cases was determined to be 95.4%; therefore, this technique may be applied with a high success rate without any assistance from intraoperative tests, such as rapid serum PTH (rPTH) assays or gamma probes, in the presence of localization results of PS and US.

Entities:  

Keywords:  Primary hyperparathyroidism; intraoperative; minimally invasive parathyroidectomy; parathyroid adenoma

Year:  2015        PMID: 25931949      PMCID: PMC4415541          DOI: 10.5152/UCD.2014.2572

Source DB:  PubMed          Journal:  Ulus Cerrahi Derg        ISSN: 1300-0705


  35 in total

Review 1.  Clinical spectrum of primary hyperparathyroidism.

Authors:  J P Bilezikian; S J Silverberg
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

3.  Minimally invasive parathyroidectomy.

Authors:  F Fausto Palazzo; Gregory P Sadler
Journal:  BMJ       Date:  2004-04-10

Review 4.  Primary hyperparathyroidism, cognition, and health-related quality of life.

Authors:  Laura H Coker; Kashemi Rorie; Larry Cantley; Kimberly Kirkland; David Stump; Nicole Burbank; Terry Tembreull; Jeff Williamson; Nancy Perrier
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

5.  Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism.

Authors:  R E Goldstein; L Blevins; D Delbeke; W H Martin
Journal:  Ann Surg       Date:  2000-05       Impact factor: 12.969

6.  Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism.

Authors:  R Mihai; F F Palazzo; F V Gleeson; G P Sadler
Journal:  Br J Surg       Date:  2007-01       Impact factor: 6.939

Review 7.  Preoperative localization and radioguided parathyroid surgery.

Authors:  Giuliano Mariani; Seza A Gulec; Domenico Rubello; Giuseppe Boni; Marco Puccini; Maria Rosa Pelizzo; Gianpiero Manca; Dario Casara; Guido Sotti; Paola Erba; Duccio Volterrani; Armando E Giuliano
Journal:  J Nucl Med       Date:  2003-09       Impact factor: 10.057

8.  Increase in presentations and procedure rates for hyperparathyroidism in Northern Sydney and New South Wales.

Authors:  Mark S Sywak; Bruce G Robinson; Phillip Clifton-Bligh; Tom S Reeve; Bruce H Barraclough; Gordon H Fick; Leigh W Delbridge
Journal:  Med J Aust       Date:  2002-09-02       Impact factor: 7.738

9.  Do patients undergoing parathyroidectomy for primary hyperparathyroidism in San Francisco, CA, and Bursa, Turkey, differ?

Authors:  Turkay Kirdak; Quan-Yang Duh; Electron Kebebew; Orlo Herrick Clark
Journal:  Am J Surg       Date:  2009-03-23       Impact factor: 2.565

Review 10.  Parathyroid carcinoma.

Authors:  Claudio Marcocci; Filomena Cetani; Mishaela R Rubin; Shonni J Silverberg; Aldo Pinchera; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

View more
  3 in total

1.  The CaPTHUS score as predictor of multiglandular primary hyperparathyroidism in a European population.

Authors:  M Mogollón-González; P Notario-Fernández; M Dominguez-Bastante; A Molina-Raya; M Serradilla-Martín; N Muñoz-Pérez; J I Arcelus-Martínez; J Villar-Del-Moral; J A Jiménez-Ríos
Journal:  Langenbecks Arch Surg       Date:  2016-04-14       Impact factor: 3.445

2.  Usefulness of the Wisconsin and CaPTHUS indices for predicting multiglandular disease in patients with primary hyperparathyroidism in a southern European population.

Authors:  Mario Serradilla-Martín; Ana Palomares-Cano; Miguel Cantalejo-Díaz; Mónica Mogollón-González; Esther Brea-Gómez; Nuria Victoria Muñoz-Pérez; Juan Ignacio Arcelus-Martínez; Jesús María Villar-Del-Moral
Journal:  Gland Surg       Date:  2021-03

3.  Validation of selective use of intraoperative PTH monitoring in parathyroidectomy.

Authors:  Alexandra Thielmann; Paul Kerr
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.